Key Highlights of the Report: Worldwide Growing Cases of Cancer: The growing incidence and prevalence of cancer is the major factor for increasing the demand for CXCR4 antagonists. Increased Focus on Combination Therapies: Combination therapy further improves the effectiveness of CXCR antagonists because it is done in combination with other agents, chemotherapeutic agents or targeted therapies...

According to the UnivDatos, the rise of cancer cases, increasing incidence of HIV, expansion of combination therapies, and increasing focus towards AI application in the drug discovery drive the CXCR4 antagonist market. As per their “CXCR4 Antagonist Market” report, the global Market was valued at USD 507.04 million in 2023, growing at a CAGR of about 12.37% during the forecast...